Follicle stimulating hormone (FSH) as a surrogate parameter for the effectiveness of endocrine therapy with or without zoledronic acid in premenopausal patients with breast cancer: An analysis of the prospective ABCSG-12 trial.
暂无分享,去创建一个
R. Greil | M. Gnant | P. Dubsky | F. Fitzal | M. Seifert | C. Singer | G. Steger | C. Marth | M. Knauer | G. Pfeiler | R. Königsberg | B. Mlineritsch | V. Bjelic-Radisic | L. Filipcic | M. Balić | H. Stöger | B. Mlineritsch